HCP Post-Congress Medical Education Campaign Brief

Role: Principal Omnichannel Medical Affairs Strategist specializing in compliant HCP educational journeys across global biopharma launches.

Context

• Medical congress: {{congress_name}}
• Physician specialty: {{target_specialty}}
• Clinical endpoint dataset: {{key_clinical_endpoint_data}}
• Jurisdictional compliance framework: {{regulatory_market}}
• Approved prescribing asset: {{prescribing_information_url}}
• Primary engagement objective: {{hcp_engagement_objective}}

Task

Produce a post-congress medical education email campaign brief that delivers scientific exchange and study interpretation to {{target_specialty}} while strictly adhering to {{regulatory_market}} compliance standards.

Method

1. Review {{congress_name}} presentation highlights and isolate high-relevance findings from {{key_clinical_endpoint_data}}.
2. Segment the recipient pool based on attendance status (in-person attendee vs. non-attendee specialist).
3. Outline a 3-part educational email narrative linking study methodology to real-world clinical implications.
4. Construct clear fair-balance integration rules, anchoring every clinical efficacy statement to safety profiles.
5. Design engagement mechanisms (e.g., interactive data visualizer, expert video commentary, CME module links) supporting {{hcp_engagement_objective}}.
6. Specify mandatory placement and linking standards for {{prescribing_information_url}}.
7. Define compliance escalation pathways for off-label inquiry handling via Medical Science Liaison (MSL) handoff.

Constraints

• MUST place fair-balance safety language and the link to {{prescribing_information_url}} in clear, prominent visual hierarchy.
• MUST NOT present exploratory or post-hoc trial endpoints as primary definitive outcomes.
• All claims MUST be verifiable against peer-reviewed citations.
• Content must be customized for high-efficiency reading suited to time-constrained clinicians.

Output format

• Strategic Objective & Fair Balance Guardrails: Concise statement of intent under {{regulatory_market}}.
• 3-Stage Message Sequence Specification: Detailed breakdown for each email (Audience variant, Subject lines, Clinical data focus, Interactive asset, Primary CTA).
• Medical Review & Annotation Plan: Matrix of planned scientific claims paired with required citation types.
• Performance & Medical Inquiry KPIs: Quantitative benchmarks for open, click-through, and MSL request rates.

Self-review

• Ensure no comparative superiority claims exist unless supported by head-to-head randomized controlled trials.
• Verify that the distinction between attendee and non-attendee messaging is clearly articulated.
• Check that the transition from digital consumption to 1:1 MSL engagement is clearly mapped.